Methods and compositions for the treatment of metabolic disorders
The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination thera...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Oppenheimer, Daniel I Kakkis, Emil D Price, Fredric D Dorenbaum, Alejandro Moser, Rudolf Groehn, Viola Egger, Thomas Blatter, Fritz |
| description | The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination therapies of BH4 and other therapeutic regimens are contemplated. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08067416</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08067416</sourcerecordid><originalsourceid>FETCH-uspatents_grants_080674163</originalsourceid><addsrcrecordid>eNrjZHD0TS3JyE8pVkjMS1FIzs8tyC_OLMnMzytWSMsvUijJSFUoKUpNLMlNzStRyE9TyE0tSUzKz8lMVkjJLM4vSkktKuZhYE1LzClO5YXS3AwKbq4hzh66pcUFiSVAfcXx6UWJIMrAwsDM3MTQzJgIJQD1lzL0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Methods and compositions for the treatment of metabolic disorders</title><source>USPTO Issued Patents</source><creator>Oppenheimer, Daniel I ; Kakkis, Emil D ; Price, Fredric D ; Dorenbaum, Alejandro ; Moser, Rudolf ; Groehn, Viola ; Egger, Thomas ; Blatter, Fritz</creator><creatorcontrib>Oppenheimer, Daniel I ; Kakkis, Emil D ; Price, Fredric D ; Dorenbaum, Alejandro ; Moser, Rudolf ; Groehn, Viola ; Egger, Thomas ; Blatter, Fritz ; Biomarin Pharmaceutical Inc ; Merck Eprova AG</creatorcontrib><description>The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination therapies of BH4 and other therapeutic regimens are contemplated.</description><language>eng</language><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8067416$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,309,781,803,886,64044</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8067416$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Oppenheimer, Daniel I</creatorcontrib><creatorcontrib>Kakkis, Emil D</creatorcontrib><creatorcontrib>Price, Fredric D</creatorcontrib><creatorcontrib>Dorenbaum, Alejandro</creatorcontrib><creatorcontrib>Moser, Rudolf</creatorcontrib><creatorcontrib>Groehn, Viola</creatorcontrib><creatorcontrib>Egger, Thomas</creatorcontrib><creatorcontrib>Blatter, Fritz</creatorcontrib><creatorcontrib>Biomarin Pharmaceutical Inc</creatorcontrib><creatorcontrib>Merck Eprova AG</creatorcontrib><title>Methods and compositions for the treatment of metabolic disorders</title><description>The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination therapies of BH4 and other therapeutic regimens are contemplated.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZHD0TS3JyE8pVkjMS1FIzs8tyC_OLMnMzytWSMsvUijJSFUoKUpNLMlNzStRyE9TyE0tSUzKz8lMVkjJLM4vSkktKuZhYE1LzClO5YXS3AwKbq4hzh66pcUFiSVAfcXx6UWJIMrAwsDM3MTQzJgIJQD1lzL0</recordid><startdate>20111129</startdate><enddate>20111129</enddate><creator>Oppenheimer, Daniel I</creator><creator>Kakkis, Emil D</creator><creator>Price, Fredric D</creator><creator>Dorenbaum, Alejandro</creator><creator>Moser, Rudolf</creator><creator>Groehn, Viola</creator><creator>Egger, Thomas</creator><creator>Blatter, Fritz</creator><scope>EFH</scope></search><sort><creationdate>20111129</creationdate><title>Methods and compositions for the treatment of metabolic disorders</title><author>Oppenheimer, Daniel I ; Kakkis, Emil D ; Price, Fredric D ; Dorenbaum, Alejandro ; Moser, Rudolf ; Groehn, Viola ; Egger, Thomas ; Blatter, Fritz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_080674163</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Oppenheimer, Daniel I</creatorcontrib><creatorcontrib>Kakkis, Emil D</creatorcontrib><creatorcontrib>Price, Fredric D</creatorcontrib><creatorcontrib>Dorenbaum, Alejandro</creatorcontrib><creatorcontrib>Moser, Rudolf</creatorcontrib><creatorcontrib>Groehn, Viola</creatorcontrib><creatorcontrib>Egger, Thomas</creatorcontrib><creatorcontrib>Blatter, Fritz</creatorcontrib><creatorcontrib>Biomarin Pharmaceutical Inc</creatorcontrib><creatorcontrib>Merck Eprova AG</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Oppenheimer, Daniel I</au><au>Kakkis, Emil D</au><au>Price, Fredric D</au><au>Dorenbaum, Alejandro</au><au>Moser, Rudolf</au><au>Groehn, Viola</au><au>Egger, Thomas</au><au>Blatter, Fritz</au><aucorp>Biomarin Pharmaceutical Inc</aucorp><aucorp>Merck Eprova AG</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Methods and compositions for the treatment of metabolic disorders</title><date>2011-11-29</date><risdate>2011</risdate><abstract>The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination therapies of BH4 and other therapeutic regimens are contemplated.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_08067416 |
| source | USPTO Issued Patents |
| title | Methods and compositions for the treatment of metabolic disorders |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T03%3A48%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Oppenheimer,%20Daniel%20I&rft.aucorp=Biomarin%20Pharmaceutical%20Inc&rft.date=2011-11-29&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08067416%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |